BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
Stephen Haynes, Osteopath and IDD Therapy provider, and Clinical Director of Active Therapy Clinic, highlights the causes of a herniated disc and what treatments are available, here.
Emmanouil Avgerinos, Ioannis Fragkos and Yufei Huang explain that for surgical teams, shared experiences and hierarchical structures matter more than you think.
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
Alex Evans, UK Country Manager for ViCentra B.V., discusses how insulin pump system Kaleido can provide solutions to reduce the practical and emotional burden of living with diabetes.
Cheryl Lythgoe, Matron at Benenden Health, answers the top five most frequently asked questions about endometriosis including what symptoms you should look out for.
